Natera Inc's Fiscal Year is From January To December - All Figures are in USD, Millions.
The item "Stock-Based-Compensation" stands at 381.42 Million United States Dollars for the trailing twelve months (TTM) period ending 06/30/2026, the highest value at least since 06/30/2014, the period currently displayed.
Natera Inc's second quarter result of 103.10 Million USD for the item "Stock Based Compensation" represents an increase of 8.40 percent compared to it's first quarter result.
Also, Natera Inc's second quarter result of 103.10 Million USD for the item "Stock Based Compensation" represents an increase of 10.43 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Natera Inc's second quarter result of 381.42 Million USD for the item "Stock Based Compensation" represents an increase of 2.62 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 21.57 percent compared to the value the year prior.
The 1 year change in percent is 21.57.
The 3 year change in percent is 136.74.
The 5 year change in percent is 327.93.
The 10 year change in percent is 3,761.34.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Stock Based Compensation | 905,699,262,464.00 |
![]() | Johnson & Johnson - Stock Based Compensation | 486,508,953,600.00 |
![]() | AbbVie Inc - Stock Based Compensation | 399,570,305,024.00 |
![]() | Roche Holding AG - Stock Based Compensation | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Stock Based Compensation | 280,205,508,085.11 |